{
    "clinical_study": {
        "@rank": "158214", 
        "acronym": "ACCELERATE", 
        "arm_group": [
            {
                "arm_group_label": "High Rate Spinal Cord Stimulation", 
                "arm_group_type": "Experimental", 
                "description": "PRECISION SCS Adapted for High-Rate SCS"
            }, 
            {
                "arm_group_label": "Commercial Rate Spinal Cord Stimulation", 
                "arm_group_type": "Active Comparator", 
                "description": "PRECISION SCS Adapted for High-Rate SCS"
            }
        ], 
        "brief_summary": {
            "textblock": "To evaluate the safety and effectiveness of the Precision Spinal Cord Stimulator System\n      Adapted for High-Rate Spinal Cord Stimulation as an aid in the management of chronic\n      intractable pain"
        }, 
        "brief_title": "Safety and Effectiveness Study of the Precision SCS System Adapted for High-Rate Spinal Cord Stimulation", 
        "completion_date": {
            "#text": "October 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Chronic Pain", 
            "Back Pain"
        ], 
        "condition_browse": {
            "mesh_term": "Back Pain"
        }, 
        "detailed_description": {
            "textblock": "To evaluate the safety and effectiveness of high rate spinal cord stimulation (HR-SCS)\n      therapy  as an aid in the management of chronic intractable pain of the trunk using the\n      Boston Scientific (BSC) PRECISION Spinal Cord Stimulator System Adapted for High-Rate Spinal\n      Cord Stimulation (PRECISION SCS System for HR)"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Have been diagnosed with chronic, intractable pain of the trunk (NRS \u2265 5) which has\n             been refractory to conservative therapy for a minimum of 90 days.\n\n          -  Be an appropriate candidate for the surgical procedures required in this study based\n             on the clinical judgment of the implanting physician\n\n          -  Be 22 years of age or older at the time of enrollment\n\n          -  Be willing and capable of giving informed consent\n\n          -  Be willing and able to comply with study-related requirements, procedures, and visits\n\n        Exclusion Criteria:\n\n          -  Have a medical condition or pain in other area(s), not intended to be treated with\n             SCS, that could interfere with study procedures, accurate pain reporting, and/or\n             confound evaluation of study endpoints, as determined by the Investigator\n\n          -  Have evidence of an active disruptive psychological or psychiatric disorder or other\n             known condition significant enough to impact perception of pain, compliance of\n             intervention and/or ability to evaluate treatment outcome, as determined by a\n             psychologist\n\n          -  Have previous spinal cord stimulation trial or is already implanted with an active\n             implantable device(s) (e.g. pacemaker, drug pump, implantable pulse generator)\n\n          -  Have a current systemic infection, or local infection in close proximity to\n             anticipated surgical field\n\n          -  Pregnant or plan to get pregnant during the course of the study or not using adequate\n             contraception.\n\n          -  Be participating in another clinical study that may influence the data collected for\n             the study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "22 Years"
        }, 
        "enrollment": {
            "#text": "406", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 19, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02093793", 
            "org_study_id": "A4007"
        }, 
        "intervention": {
            "arm_group_label": [
                "High Rate Spinal Cord Stimulation", 
                "Commercial Rate Spinal Cord Stimulation"
            ], 
            "description": "Comparison of spinal cord stimulation parameters", 
            "intervention_name": "PRECISION SCS Adapted for High-Rate SCS", 
            "intervention_type": "Device", 
            "other_name": "Boston Scientific PRECISION Spinal Cord Stimulator System"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "June 3, 2014", 
        "location": {
            "contact": {
                "email": "BSNClinicalTrials@bsci.com", 
                "phone": "855-213-9890"
            }, 
            "facility": {
                "address": {
                    "city": "Valencia", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "91355"
                }, 
                "name": "Boston Scientific Clinical Research Information Toll Free Number"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized Controlled Study to Evaluate the Safety and Effectiveness of the Precision Spinal Cord Stimulator System Adapted for High-Rate Spinal Cord Stimulation", 
        "overall_contact": {
            "email": "natalie.bloomlyons@bsci.com", 
            "last_name": "Natalie Bloom Lyons, MA", 
            "phone": "763-228-9040"
        }, 
        "overall_contact_backup": {
            "email": "diane.bowers@bsci.com", 
            "last_name": "Diane Bowers", 
            "phone": "661-949-4175"
        }, 
        "overall_official": {
            "affiliation": "University of California, San Diego", 
            "last_name": "Mark Wallace, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "May 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Low back pain responder rate from Baseline", 
            "safety_issue": "No", 
            "time_frame": "3 months post-activation"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02093793"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Boston Scientific Corporation", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Boston Scientific Corporation", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2014"
    }
}